July 2nd 2025
A multicenter US study confirms that RBL is a safe and effective microbiota-based therapy with sustained remission in a high-risk, comorbid population.
Top 5 Infectious Disease News Stories Week of November 30-December 6
December 7th 2024This week, a Mayo Clinic study found that removing C diff from gastrointestinal pathogen panels reduced unnecessary treatments, a Salmonella outbreak was linked to cucumbers, and a hepatitis C therapy achieved a 98% sustained virologic response in non-cirrhotic patients, among other developments.
Read More
Head-to-Head Comparison of Treatments for Recurrent C difficile Infection
November 14th 202417 randomized controlled trials involving 4,148 patients assessed the efficacy of various treatments, finding that fecal microbiota transplantation via the lower gastrointestinal route was the most effective.
Read More
Due to FDA Policy Change, Fecal Microbiota Transplants Are in a Tenuous Position
November 13th 2024The country’s largest fecal distributor, OpenBiome, could be prevented from offering the product next year if the FDA does not approve the product used for fecal microbiota transplants to treat fulminant C difficile.
Watch
Top 5 Infectious Disease New Stories Week of November 2-8
November 9th 2024From improving infection control and antibiotic stewardship, identifying RT 027 as a risk factor for vancomycin resistance in C diff, developing a universal flu vaccine, better management for drug-resistant pathogens, and more.
Read More
Top 5 Infectious Disease News Stories Week Of October 18-25
October 26th 2024Experts highlighted research showing that even mild COVID can result in cognitive impairment including brain fog and IQ decline, the FDA approved Pfizer's RSV vaccine for adults aged 18 to 59, E coli outbreak linked to McDonald's Quarter Pounders, and more.
Read More